NSPR
InspireMD, Inc.
Price Chart
Latest Quote
$0.72
+0.01 (+0.86%)
Current Price
| Previous Close | $0.71 |
| Open | $0.72 |
| Day High | $0.76 |
| Day Low | $0.72 |
| Volume | 96,018 |
Stock Information
| Shares Outstanding | 46.84M |
| Total Debt | $3.11M |
| Cash Equivalents | $41.57M |
| Revenue | $10.85M |
| Net Income | $-51.31M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $32.83M |
| EPS (TTM) | $-0.70 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-4.92M |
| Sales | $10.85M |
| Income | $-51.31M |
| Book/sh | $0.93 |
| Cash/sh | $0.89 |
| Employees | 127 |
Financial Ratios
| Quick Ratio | 4.70 |
| Current Ratio | 5.15 |
| Debt/Eq | 7.13 |
Returns & Margins
| ROA | -68.49% |
| ROE | -142.60% |
| Gross Margin | 28.06% |
| Operating Margin | -411.36% |
Ownership
| Insider Ownership | 19.83% |
| Institutional Ownership | 48.68% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.15 |
| P/S | 3.03 |
| P/B | 0.75 |
Analyst Data
| Recommendation | buy |
| Target Price | $3.67 |
Technical Indicators
| SMA20 | $0.83 |
| SMA50 | $1.05 |
| SMA200 | $1.72 |
| RSI | 17.06 |
| ATR | 0.0937 |
| Shares Float | 26.29M |
| Short Float | 0.04% |
| Short Ratio | 0.03 |
| Volatility | 0.74 |
| Rel Volume | 0.74 |
Performance History
| Week | -7.76% |
| Month | -31.94% |
| Quarter | -59.71% |
| 6 Months | -64.95% |
| YTD | -62.31% |
| Year | -71.50% |
| 3 Years | -65.80% |
| 5 Years | -87.59% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $0.70 | 130,906 |
| 2026-06-22 | $0.72 | 96,100 |
| 2026-06-18 | $0.71 | 105,000 |
| 2026-06-17 | $0.74 | 44,800 |
| 2026-06-16 | $0.71 | 100,600 |
| 2026-06-15 | $0.76 | 600,000 |
| 2026-06-12 | $0.73 | 121,600 |
| 2026-06-11 | $0.73 | 107,900 |
| 2026-06-10 | $0.78 | 183,900 |
| 2026-06-09 | $0.77 | 138,200 |
| 2026-06-08 | $0.82 | 177,800 |
| 2026-06-05 | $0.88 | 215,300 |
| 2026-06-04 | $0.93 | 111,900 |
| 2026-06-03 | $0.96 | 29,400 |
| 2026-06-02 | $1.01 | 140,500 |
| 2026-06-01 | $0.99 | 245,200 |
| 2026-05-29 | $0.92 | 252,500 |
| 2026-05-28 | $0.90 | 318,500 |
| 2026-05-27 | $0.88 | 270,700 |
| 2026-05-26 | $0.95 | 142,300 |
About InspireMD, Inc.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
đ° Latest News
InspireMD Posts Positive CGUARDIANS II Data for CGuard Prime TCAR
Zacks âĸ 2026-06-16T16:41:00Z
InspireMD, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-05T12:30:00Z
InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-04T21:50:07Z
InspireMD (NSPR) Q4 2025 Earnings Transcript
Motley Fool âĸ 2026-05-04T21:28:00Z
InspireMD (NSPR) Q2 2025 Earnings Transcript
Motley Fool âĸ 2026-05-04T21:26:53Z
After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR)
Zacks âĸ 2026-04-08T13:35:01Z
InspireMD Inc (NSPR) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Advancements
GuruFocus.com âĸ 2026-03-18T19:02:46ZInspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue Estimates
Zacks âĸ 2026-03-18T12:15:02Z
NeuroPace, Inc. (NPCE) Reports Q4 Loss, Beats Revenue Estimates
Zacks âĸ 2026-03-03T22:35:02Z
InspireMD (NASDAQ:NSPR) shareholders have endured a 81% loss from investing in the stock five years ago
Simply Wall St. âĸ 2026-01-10T14:41:42Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $6,330,000 | $5,503,000 | $4,398,000 | $4,054,000 |
| Cost Of Revenue | $6,330,000 | $5,503,000 | $4,398,000 | $4,054,000 |
| Total Revenue | $8,979,000 | $7,009,000 | $6,205,000 | $5,171,000 |
| Operating Revenue | $8,979,000 | $7,009,000 | $6,205,000 | $5,171,000 |
| Expenses | ||||
| Total Expenses | $58,593,000 | $40,512,000 | $27,348,000 | $23,884,000 |
| Net Non Operating Interest Income Expense | $891,000 | $1,557,000 | $1,292,000 | $250,000 |
| Operating Expense | $52,263,000 | $35,009,000 | $22,950,000 | $19,830,000 |
| Selling And Marketing Expense | $16,553,000 | $6,069,000 | $3,865,000 | $3,664,000 |
| General And Administrative Expense | $20,707,000 | $15,306,000 | $11,104,000 | $8,356,000 |
| Interest Expense | - | - | - | - |
| Interest Expense Non Operating | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-48,786,000 | $-32,005,000 | $-19,916,000 | $-18,491,000 |
| Net Interest Income | $891,000 | $1,557,000 | $1,292,000 | $250,000 |
| Interest Income | $891,000 | $1,557,000 | $1,292,000 | $250,000 |
| Normalized Income | $-48,786,000 | $-32,005,000 | $-19,916,000 | $-18,491,000 |
| Net Income From Continuing And Discontinued Operation | $-48,786,000 | $-32,005,000 | $-19,916,000 | $-18,491,000 |
| Total Operating Income As Reported | $-49,614,000 | $-33,503,000 | $-21,143,000 | $-18,713,000 |
| Net Income Common Stockholders | $-48,786,000 | $-32,005,000 | $-19,916,000 | $-18,491,000 |
| Net Income | $-48,786,000 | $-32,005,000 | $-19,916,000 | $-18,491,000 |
| Net Income Including Noncontrolling Interests | $-48,786,000 | $-32,005,000 | $-19,916,000 | $-18,491,000 |
| Net Income Continuous Operations | $-48,786,000 | $-32,005,000 | $-19,916,000 | $-18,491,000 |
| Pretax Income | $-48,723,000 | $-31,946,000 | $-19,851,000 | $-18,463,000 |
| Interest Income Non Operating | $891,000 | $1,557,000 | $1,292,000 | $250,000 |
| Operating Income | $-49,614,000 | $-33,503,000 | $-21,143,000 | $-18,713,000 |
| Gross Profit | $2,649,000 | $1,506,000 | $1,807,000 | $1,117,000 |
| Per Share | ||||
| Diluted EPS | $-0.76 | $-0.76 | $-0.82 | $-2.35 |
| Basic EPS | $-0.76 | $-0.76 | $-0.82 | $-2.35 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-49,138,000 | $-33,223,000 | $-20,911,000 | $-18,525,000 |
| Reconciled Depreciation | $476,000 | $280,000 | $232,000 | $188,000 |
| EBITDA (Bullshit earnings) | $-49,138,000 | $-33,223,000 | $-20,911,000 | $-18,525,000 |
| EBIT | $-49,614,000 | $-33,503,000 | $-21,143,000 | $-18,713,000 |
| Diluted Average Shares | $64,325,810 | $41,928,360 | $24,268,181 | $7,871,814 |
| Basic Average Shares | $64,325,810 | $41,928,360 | $24,268,181 | $7,871,814 |
| Diluted NI Availto Com Stockholders | $-48,786,000 | $-32,005,000 | $-19,916,000 | $-18,491,000 |
| Tax Provision | $63,000 | $59,000 | $65,000 | $28,000 |
| Research And Development | $15,003,000 | $13,634,000 | $7,981,000 | $7,810,000 |
| Selling General And Administration | $37,260,000 | $21,375,000 | $14,969,000 | $12,020,000 |
| Other Gand A | $20,707,000 | $15,306,000 | $11,104,000 | $8,356,000 |
Fetched: 2026-06-21
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $55,201,000 | $36,086,000 | $39,501,000 | $17,393,000 |
| Total Assets | $69,404,000 | $46,807,000 | $47,643,000 | $24,653,000 |
| Total Non Current Assets | $7,933,000 | $6,286,000 | $3,484,000 | $3,327,000 |
| Non Current Prepaid Assets | $442,000 | $426,000 | $0 | - |
| Current Assets | $61,471,000 | $40,521,000 | $44,159,000 | $21,326,000 |
| Prepaid Assets | $1,296,000 | $1,060,000 | $578,000 | $655,000 |
| Inventory | $3,396,000 | $2,570,000 | $2,106,000 | $1,621,000 |
| Receivables | $2,568,000 | $2,254,000 | $2,452,000 | $1,247,000 |
| Other Receivables | $400,000 | $682,000 | $648,000 | $213,000 |
| Accounts Receivable | $2,168,000 | $1,572,000 | $1,804,000 | $1,034,000 |
| Cash Cash Equivalents And Short Term Investments | $54,211,000 | $34,637,000 | $39,023,000 | $17,803,000 |
| Cash And Cash Equivalents | $8,939,000 | $18,916,000 | $9,640,000 | $4,632,000 |
| Debt | ||||
| Total Debt | $3,290,000 | $2,338,000 | $1,595,000 | $1,614,000 |
| Long Term Debt And Capital Lease Obligation | $2,224,000 | $1,796,000 | $1,038,000 | $1,195,000 |
| Current Debt And Capital Lease Obligation | $1,066,000 | $542,000 | $557,000 | $419,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $14,203,000 | $10,721,000 | $8,142,000 | $7,260,000 |
| Total Non Current Liabilities Net Minority Interest | $3,491,000 | $3,043,000 | $2,122,000 | $2,190,000 |
| Current Liabilities | $10,712,000 | $7,678,000 | $6,020,000 | $5,070,000 |
| Payables And Accrued Expenses | $4,721,000 | $3,722,000 | $3,275,000 | $2,798,000 |
| Payables | $1,591,000 | $1,509,000 | $1,129,000 | $789,000 |
| Other Payable | $336,000 | $255,000 | $190,000 | $130,000 |
| Accounts Payable | $1,255,000 | $1,254,000 | $939,000 | $659,000 |
| Equity | ||||
| Common Stock Equity | $55,201,000 | $36,086,000 | $39,501,000 | $17,393,000 |
| Total Equity Gross Minority Interest | $55,201,000 | $36,086,000 | $39,501,000 | $17,393,000 |
| Stockholders Equity | $55,201,000 | $36,086,000 | $39,501,000 | $17,393,000 |
| Retained Earnings | $-302,292,000 | $-253,506,000 | $-221,501,000 | $-201,585,000 |
| Other | ||||
| Ordinary Shares Number | $43,532,281 | $26,611,033 | $21,841,215 | $8,330,918 |
| Share Issued | $43,532,281 | $26,611,033 | $21,841,215 | $8,330,918 |
| Tangible Book Value | $55,201,000 | $36,086,000 | $39,501,000 | $17,393,000 |
| Invested Capital | $55,201,000 | $36,086,000 | $39,501,000 | $17,393,000 |
| Working Capital | $50,759,000 | $32,843,000 | $38,139,000 | $16,256,000 |
| Capital Lease Obligations | $3,290,000 | $2,338,000 | $1,595,000 | $1,614,000 |
| Total Capitalization | $55,201,000 | $36,086,000 | $39,501,000 | $17,393,000 |
| Additional Paid In Capital | $357,489,000 | $289,589,000 | $261,000,000 | $218,977,000 |
| Capital Stock | $4,000 | $3,000 | $2,000 | $1,000 |
| Common Stock | $4,000 | $3,000 | $2,000 | $1,000 |
| Employee Benefits | $1,267,000 | $1,247,000 | $1,084,000 | $995,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $1,267,000 | $1,247,000 | $1,084,000 | $995,000 |
| Long Term Capital Lease Obligation | $2,224,000 | $1,796,000 | $1,038,000 | $1,195,000 |
| Current Capital Lease Obligation | $1,066,000 | $542,000 | $557,000 | $419,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $4,925,000 | $3,414,000 | $2,188,000 | $1,853,000 |
| Current Accrued Expenses | $3,130,000 | $2,213,000 | $2,146,000 | $2,009,000 |
| Defined Pension Benefit | $1,149,000 | $1,129,000 | $951,000 | $856,000 |
| Net PPE | $6,342,000 | $4,731,000 | $2,533,000 | $2,471,000 |
| Accumulated Depreciation | $-2,725,000 | $-2,320,000 | $-2,040,000 | $-1,908,000 |
| Gross PPE | $9,067,000 | $7,051,000 | $4,573,000 | $4,379,000 |
| Leases | $1,087,000 | $861,000 | $724,000 | $494,000 |
| Other Properties | $2,758,000 | $2,360,000 | $1,473,000 | $1,554,000 |
| Machinery Furniture Equipment | $5,222,000 | $3,830,000 | $2,376,000 | $2,331,000 |
| Finished Goods | $352,000 | $18,000 | $210,000 | $179,000 |
| Work In Process | $930,000 | $638,000 | $562,000 | $510,000 |
| Raw Materials | $2,114,000 | $1,914,000 | $1,334,000 | $932,000 |
| Other Short Term Investments | $45,272,000 | $15,721,000 | $29,383,000 | $13,171,000 |
Fetched: 2026-06-21
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-36,765,000 | $-23,270,000 | $-16,757,000 | $-16,015,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-35,103,000 | $-21,868,000 | $-16,376,000 | $-15,542,000 |
| Cash Flow From Continuing Operating Activities | $-35,103,000 | $-21,868,000 | $-16,376,000 | $-15,542,000 |
| Operating Gains Losses | $-293,000 | $72,000 | $67,000 | $78,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,662,000 | $-1,402,000 | $-381,000 | $-473,000 |
| Investing Cash Flow | $-30,560,000 | $12,641,000 | $-16,092,000 | $8,441,000 |
| Cash Flow From Continuing Investing Activities | $-30,560,000 | $12,641,000 | $-16,092,000 | $8,441,000 |
| Net Other Investing Changes | $279,000 | $-87,000 | $-79,000 | $-86,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $38,714,000 | $1,598,000 | $37,534,000 | $0 |
| Financing Cash Flow | $55,569,000 | $18,452,000 | $37,534,000 | $-140,000 |
| Cash Flow From Continuing Financing Activities | $55,569,000 | $18,452,000 | $37,534,000 | $-140,000 |
| Net Common Stock Issuance | $38,714,000 | $1,598,000 | $37,534,000 | $0 |
| Common Stock Issuance | $38,714,000 | $1,598,000 | $37,534,000 | $0 |
| Net Other Financing Charges | - | - | - | $-140,000 |
| Other | ||||
| End Cash Position | $8,939,000 | $18,916,000 | $9,640,000 | $4,632,000 |
| Beginning Cash Position | $18,916,000 | $9,640,000 | $4,632,000 | $12,004,000 |
| Effect Of Exchange Rate Changes | $117,000 | $51,000 | $-58,000 | $-131,000 |
| Changes In Cash | $-10,094,000 | $9,225,000 | $5,066,000 | $-7,241,000 |
| Proceeds From Stock Option Exercised | $16,855,000 | $16,854,000 | $0 | - |
| Net Investment Purchase And Sale | $-29,192,000 | $14,130,000 | $-15,644,000 | $9,000,000 |
| Sale Of Investment | $27,648,000 | $29,000,000 | $24,500,000 | $28,000,000 |
| Purchase Of Investment | $-56,840,000 | $-14,870,000 | $-40,144,000 | $-19,000,000 |
| Net PPE Purchase And Sale | $-1,647,000 | $-1,402,000 | $-369,000 | $-473,000 |
| Sale Of PPE | $15,000 | $0 | $12,000 | $0 |
| Purchase Of PPE | $-1,662,000 | $-1,402,000 | $-381,000 | $-473,000 |
| Change In Working Capital | $1,106,000 | $736,000 | $-801,000 | $395,000 |
| Change In Payables And Accrued Expense | $2,482,000 | $1,484,000 | $812,000 | $724,000 |
| Change In Payable | $2,482,000 | $1,484,000 | $812,000 | $724,000 |
| Change In Account Payable | $1,000 | $315,000 | $280,000 | $-234,000 |
| Change In Prepaid Assets | $-236,000 | $-482,000 | $77,000 | $7,000 |
| Change In Inventory | $-826,000 | $-464,000 | $-485,000 | $-478,000 |
| Change In Receivables | $-314,000 | $198,000 | $-1,205,000 | $142,000 |
| Changes In Account Receivables | $-596,000 | $232,000 | $-770,000 | $190,000 |
| Other Non Cash Items | $421,000 | $-195,000 | $291,000 | $-64,000 |
| Stock Based Compensation | $12,332,000 | $10,138,000 | $4,490,000 | $2,352,000 |
| Unrealized Gain Loss On Investment Securities | $-359,000 | $-894,000 | $-739,000 | $0 |
| Depreciation Amortization Depletion | $476,000 | $280,000 | $232,000 | $188,000 |
| Depreciation And Amortization | $476,000 | $280,000 | $232,000 | $188,000 |
| Depreciation | $476,000 | $280,000 | $232,000 | - |
| Pension And Employee Benefit Expense | $-279,000 | $72,000 | $73,000 | $78,000 |
| Gain Loss On Sale Of PPE | $-14,000 | $0 | $-6,000 | $0 |
| Net Income From Continuing Operations | $-48,786,000 | $-32,005,000 | $-19,916,000 | $-18,491,000 |
| Change In Other Working Capital | - | - | - | - |
Fetched: 2026-06-21